United States · FDA National Drug Code directory
Syfovre
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73606-020_76e1d7d9-903f-49c1-be3a-617f682e79e7
- Product NDC
- 73606-020
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Pegcetacoplan
- Labeler
- Apellis Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230217
- Source listing expiry
- 20261231
Source-listed ingredients
- PEGCETACOPLAN — 15 mg/.1mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (73606-020-01) / 3 mL in 1 VIAL, GLASS · 73606-020-01
- 1 VIAL, GLASS in 1 CARTON (73606-020-02) / 3 mL in 1 VIAL, GLASS · 73606-020-02
- 1 VIAL, GLASS in 1 CARTON (73606-020-11) / 3 mL in 1 VIAL, GLASS · 73606-020-11
- 1 VIAL, GLASS in 1 CARTON (73606-020-12) / 3 mL in 1 VIAL, GLASS · 73606-020-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →